Report Scope:
This report is focused on newer drugs and innovations in chemical compounds, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control, drugs used for symptomatic treatment and not for the elimination of the virus from the host and details on manufacturers and suppliers of non-branded generics. This report will also highlight the current and future market potential of antibiotics with detailed analysis of the competitive environment. Drivers, restraints, opportunities, pricing analysis, impact of COVID-19, other infectious diseases and a regulatory scenario assessment are covered, along with a market projection for 2027 and market share assessment for key players.
The report segments the market for antibiotics based on product type, route of administration, application and geographical region. Based on product type, the market is segmented into cell wall inhibitors, protein inhibitors, DNA and other inhibitors (RNA, mycolic acid, folic acid). Based on route of administration, the market is segmented into oral and topical.
By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, South America and the Middle East and Africa. Detailed analysis of major countries (U.S., Germany, UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa) will be covered in the regional segment. For market estimates, data will be provided for 2021 as the base year, with estimates for 2022 and forecast value for 2027.
Report Includes:
- 22 data tables and 16 additional tables
- An overview of the global market for antibiotics within the pharmaceutical industry
- Analyses of the global market trends, with data corresponding to market size for 2019-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2027
- Information on market growth drivers and opportunities, industry supply chain structure, regulatory developments, technological advancements, and demographic shifts shaping the overall antibiotics marketplace
- Evaluation of market growth during the forecast period, and deep dive of market share analysis data basis of product type, product, route of administration, end-user, and geographical region
- Country specific data and analysis for the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and South Africa
- Identification of the companies best positioned to meet the global market demand for antibiotic drugs on the basis of their proprietary technologies, M&A deals, collaborations, JVs and other strategic alliances
- Company profiles of major players within the industry, including Abbott, F. Hoffmann-La Roche AG, Merck & Co. Inc., Pfizer Inc. and Sanofi
Summary:
The global market for antibiotics was valued at $39.2 billion in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of 4.2% to reach $49.6 billion by the end of 2027. The antibiotic market growth outlook is positive with significant growth potential for cell wall inhibitor and protein inhibitor antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobialresistant drugs at affordable prices. At the same time, factors such as rising disposable incomes and increasing spending on healthcare in emerging markets, increasing grants from government agencies for antibiotic drugs R&D and rising incidence of infectious diseases are contributing to the growth of the market.
Pharmaceutical companies and governments are increasingly working together in partnerships and collaborations to provide funding and to implement incentive programs for the R&D of antibiotics. These partnerships provide financial and technical assistance across different clinical development phases. Various programs, such as the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), the Innovative Medicines Initiative's (IMI's) New Drugs for Bad Bugs (ND4BB) program, Biomedical Advanced Research and Development Authority's (BARDA) Broad Spectrum Antimicrobials Program and Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), have been implemented for the development of novel antibiotics by focusing on R&D gaps.
Additionally, The Davos Declaration was signed in Jan. 2016 by more than 100 companies and trade associations (Allergan, AstraZeneca, GSK, Pfizer and Sanofi). This declaration focused on investments in R&D to meet public health needs, reducing the development of antimicrobial resistance and improving access to antibiotics.
Pharmaceutical companies are increasingly adopting 3D printing technology for the discovery and development of new antibiotics to reduce manufacturing costs and increase production efficiency. In 2018, a 3D-printed fluorescence imaging box (PFIbox) was developed by McMaster University's laboratory for antibiotics discovery. This box is capable of analyzing more than 6,000 samples of bacteria at a time and provides vital information on bacterial response.
The global antibiotic market is segmented based on the product, route of administration, end user and region.
Antibiotics: Technologies and Global Markets
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Overview of Antibiotics
Common Side Effects of Antibiotics
Classification of Antibiotics
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Antibiotic Classes
Antibiotic Classification, by Source
Overview of Gram-Negative and Gram-Positive Bacteria
Route of Administration
Trends in the Market for Antibiotics
New Antibiotic Development
Antibiotic Drug Development, Smaller Pharmaceutical Firms
Growing Public/Private Partnerships
Chapter 4 Market Dynamics
Market Drivers
Growth Driven by Antibiotics
Rising Elder Population and Infection Rate
Increasing Hospital-acquired Infections
Improved Awareness
Market Restraints
Antibiotic-resistant Infections
Generics
Declining R&D Investment
Side Effects of Antibiotics
Market Opportunities
Market Expansion
Novel Antibacterial Agents
Chapter 5 Market Breakdown, by Product
Global Market for Antibiotics by Product
Cell Wall Inhibitors
Protein Inhibitors
DNA Inhibitors
Other Types of Inhibitors
Chapter 6 Market Breakdown, by Route of Administration
Global Market for Antibiotics by Route of Administration
Oral Antibiotics
Topical Antibiotics
Other Routes of Administration
Chapter 7 Market Breakdown, by Region
Global Market for Antibiotics by Region
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa
Chapter 8 Impact of COVID-19 on the Pharmaceutical Industry
Short-term Impact
Change in Demand
Shift of Communication and Promotions to Remote Interactions
R&D Changes
Long-term Impact
Delayed Approvals for Non-COVID-related Pharmaceutical Products
Self-sufficiency in Pharma
Pharmaceutical Industry Growth Slowdown
Changes in Consumption Trends in Health-related Products
Chapter 9 Clinical Developments and Pipeline Products
Respiratory Tract Infections
Chapter 10 Value Chain Analysis
Introduction
China: Center of Microbial Threat
Chapter 11 Regulatory Scenario
FDA and International Regulation
Recent Regulatory Reforms
Ketek Case Study
Chapter 12 Competitive Landscape
Global Company Market Share Analysis
Mergers, Collaborations, Partnerships and Acquisitions
Chapter 13 Company Profiles
ABBOTT
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON
MERCK & CO. INC.
PFIZER INC.
SANOFI
VIATRIS INC.
Chapter 14 Appendix: Acronyms
List of Tables
Summary Table A : Global Market for Antibiotics, by Product, Through 2027
Summary Table B : Global Market for Antibiotics, by Route of Administration, Through 2027
Table 1 : Major Differences, Gram-Positive and Gram-Negative Organisms
Table 2 : Proportion of Resistant Strains, by WHO Region
Table 3 : Global Market for Antibiotics, by Product, Through 2027
Table 4 : Global Market for Cell Wall Inhibitor, by Product, Through 2027
Table 5 : Global Market for Cell Wall Inhibitors, by Region, Through 2027
Table 6 : Global Market for Protein Inhibitors, by Product, Through 2027
Table 7 : Global Market for Protein Inhibitors, by Region, Through 2025
Table 8 : Global Market for DNA Inhibitors, by Product, Through 2027
Table 9 : Global Market for DNA Inhibitors, by Region, Through 2027
Table 10 : Global Market for Other Types of Inhibitors, by Region, Through 2027
Table 11 : Global Market for Antibiotics, by Route of Administration, Through 2027
Table 12 : Global Market for Antibiotics, by Region, Through 2027
Table 13 : North American Market for Antibiotics, by Product, Through 2027
Table 14 : North American Market for Antibiotics, by Country, Through 2027
Table 15 : European Market for Antibiotics, by Product, Through 2025
Table 16 : European Market for Antibiotics, by Country, Through 2025
Table 17 : Asia-Pacific Market for Antibiotics, by Product, Through 2027
Table 18 : Asia-Pacific Market for Antibiotics, by Country, Through 2027
Table 19 : Latin American Market for Antibiotics, by Product, Through 2027
Table 20 : Latin American Market for Antibiotics, by Country, Through 2025
Table 21 : Middle Eastern and African Market for Antibiotics, by Product, Through 2027
Table 22 : Middle Eastern and African Market for Antibiotics, by Country, Through 2027
Table 23 : Antibiotics and Combinations in Global Clinical Development, Recent Approvals,2023
Table 24 : FDA-approved Antibacterial Drugs, 2018
Table 25 : FDA-Approved Antibacterial Drugs, 2019
Table 26 : Abbott: Antibiotics Product Portfolio
Table 27 : F. Hoffmann-La Roche AG: Antibiotics Product Portfolio
Table 28 : GlaxoSmithKline Plc: Antibiotics Product Portfolio
Table 29 : Johnson & Johnson: Antibiotics Product Portfolio
Table 30 : Merck & Co. Inc.: Antibiotics Product Portfolio
Table 31 : Merck & Co. Inc.: Antibiotic Drug Overview
Table 32 : Pfizer Inc.: Antibiotics Product Portfolio
Table 33 : Sanofi: Antibiotics Product Portfolio
Table 34 : Sanofi S.A.: Antibiotic Drugs Overview
Table 35 : Vitaris Inc.: Antibiotics Product Portfolio
Table 36 : Acronyms Used in this Report
List of Figures
Summary Figure A : Global Market Shares of Antibiotics, by Product, 2021
Summary Figure B : Global Market Shares of Antibiotics, by Route of Administration, 2021
Figure 1 : Types of Antibiotics, by Origin Source
Figure 2 : Share of API Manufacturing Facilities for All Drugs, by Country/Region, Aug. 2019
Figure 3 : Share of Population Aged 65+, by Region, 2019
Figure 4 : Forecasted Share of Population Aged 65+, by Region, 2050
Figure 5 : Increase in Elder Population, 2011 and 2050
Figure 6 : Distribution of Population with Hospital-acquired Infections, U.S., 2020
Figure 7 : Socioeconomic and Political Factors Contributing to Antibiotic Resistance
Figure 8 : Global Market Shares of Antibiotics, by Product, 2021
Figure 9 : Global Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 10 : Global Market for Cell Wall Inhibitors, by Region, 2021-2027
Figure 11 : Global Market Shares of Protein Inhibitors, by Product, 2021
Figure 12 : Global Market for Protein Inhibitors, by Region, 2019-2027
Figure 13 : Global Market Shares of DNA Inhibitors, by Product, 2019
Figure 14 : Global Market for DNA Inhibitors, by Region, 2019-2027
Figure 15 : Global Market for Other Types of Inhibitors, by Region, 2019-2027
Figure 16 : Global Market Shares of Antibiotics, by Route of Administration, 2021
Figure 17 : Global Market Shares of Antibiotics, by Region, 2021
Figure 18 : North American Market Shares of Antibiotics, by Product, 2021
Figure 19 : North American Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 20 : North American Market Shares of Protein Inhibitors, by Product, 2021
Figure 21 : North American Market Shares of DNA Inhibitors, by Product, 2021
Figure 22 : North American Market Shares of Antibiotics, by Country, 2022
Figure 23 : U.S. Market for Antibiotics, 2019-2027
Figure 24 : Canadian Market for Antibiotics, 2019-2027
Figure 25 : Mexican Market for Antibiotics, 2019-2027
Figure 26 : European Market Shares of Antibiotics, by Product, 2021
Figure 27 : European Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 28 : European Market Shares of Protein Inhibitors, by Product, 2021
Figure 29 : European Market Shares of DNA Inhibitors, by Product, 2021
Figure 30 : European Market Shares of Antibiotics, by Country, 2021
Figure 31 : German Market for Antibiotics, 2019-2027
Figure 32 : French Market for Antibiotics, 2019-2027
Figure 33 : U.K. Market for Antibiotics, 2019-2027
Figure 34 : Italian Market for Antibiotics, 2019-2027
Figure 35 : Spanish Market for Antibiotics, 2019-2027
Figure 36 : Rest of European Market for Antibiotics, 2019-2027
Figure 37 : Asia-Pacific Market Shares of Antibiotics, by Product, 2021
Figure 38 : Asia-Pacific Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 39 : Asia-Pacific Market Shares of Protein Inhibitors, by Product, 2021
Figure 40 : Asia-Pacific Market Shares of DNA Inhibitors, by Product, 2021
Figure 41 : Asia-Pacific Market Shares of Antibiotics, by Country, 2021
Figure 42 : Japanese Market for Antibiotics, 2019-2027
Figure 43 : Chinese Market for Antibiotics, 2019-2027
Figure 44 : Indian Market for Antibiotics, 2019-2027
Figure 45 : Australia and New Zealand Market for Antibiotics, 2019-2027
Figure 46 : Rest of Asia-Pacific Market for Antibiotics, 2019-2027
Figure 47 : Latin American Market Shares of Antibiotics, by Product, 2021
Figure 48 : Latin American Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 49 : Latin American Market Shares of Protein Inhibitors, by Product, 2021
Figure 50 : Latin American Market Shares of DNA Inhibitors, by Product, 2021
Figure 51 : Latin American Market Shares of Antibiotics, by Country, 2021
Figure 52 : Brazilian Market for Antibiotics, 2019-2027
Figure 53 : Argentinian Market for Antibiotics, 2019-2027
Figure 54 : Rest of Latin American Market for Antibiotics, 2019-2027
Figure 55 : Middle Eastern and African Market Shares of Antibiotics, by Product, 2021
Figure 56 : Middle Eastern and African Market Shares of Cell Wall Inhibitors, by Product, 2021
Figure 57 : Middle Eastern and African Market Shares of Protein Inhibitors, by Product, 2021
Figure 58 : Middle Eastern and African Market Shares of DNA Inhibitors, by Product, 2021
Figure 59 : Middle Eastern and African Market Shares of Antibiotics, by Country, 2021
Figure 60 : GCC Countries' Market for Antibiotics , 2019-2027
Figure 61 : South African Market for Antibiotics, 2021-2027
Figure 62 : Rest of Middle Eastern and African Market for Antibiotics, 2019-2027
Figure 63 : Impact of COVID-19 on the Pharmaceutical Industry
Figure 64 : Value Chain Analysis
Figure 65 : Global Market Shares of Antibiotics, by Manufacturer, 2021
Figure 66 : Abbott: Annual Revenue, 2019-2021
Figure 67 : Abbott: Revenue Shares, by Country/Region, 2021
Figure 68 : Abbott: Revenue Shares, by Business Unit, 2021
Figure 69 : F. Hoffmann-La Roche AG: Annual Revenue, 2019-2022
Figure 70 : F. Hoffmann-La Roche AG: Revenue Shares in Pharmaceutical Segment, by Country/Region, 2022
Figure 71 : F. Hoffmann-La Roche AG: Revenue Shares, by Business Segment, 2022
Figure 72 : F. Hoffmann-La Roche AG: Revenue Shares, by Therapeutic Segment, 2022
Figure 73 : GlaxoSmithKline Plc: Annual Revenue, 2020-2022
Figure 74 : GlaxoSmithKline Plc: Revenue Shares, by Pharmaceutical, 2022
Figure 75 : GlaxoSmithKline Plc: Revenue Shares, by Product Category, 2022
Figure 76 : GlaxoSmithKline Plc: Revenue Shares, by Region, 2022
Figure 77 : Johnson & Johnson: Annual Revenue, 2019-2021
Figure 78 : Johnson & Johnson: Revenue Shares, by Region, 2021
Figure 79 : Johnson & Johnson: Revenue Shares, by Business Unit, 2021
Figure 80 : Merck & Co. Inc.: Annual Revenue, 2020-2022
Figure 81 : Merck & Co. Inc.: Revenue Shares, by Region, 2019
Figure 82 : Merck & Co. Inc.: Revenue Shares, by Business Unit, 2019
Figure 83 : Pfizer Inc.: Annual Revenue, 2020-2022
Figure 84 : Pfizer Inc.: Revenue Shares, by Region, 2022
Figure 85 : Pfizer Inc.: Revenue Shares, by Country, 2022
Figure 86 : Pfizer Inc.: Revenue Shares, by Business Segment, 2022
Figure 87 : Sanofi: Annual Revenue, 2020-2022
Figure 88 : Sanofi: Revenue Shares, by Region/Country, 2022
Figure 89 : Sanofi: Revenue Shares, by Business Segment, 2022
Figure 90 : Viatris Inc.: Annual Revenue, 2020-2022
Figure 91 : Vitaris Inc.: Revenue Shares, by Region, 2022
Figure 92 : Vitaris Inc.: Revenue Shares, by Business Unit, 2022
Global Cephalosporin Market Insights, Forecast to 2029
Published: 21-Sep-2023 Price: US 4900 Onwards Pages: 126
Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.
Cephalosporin originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".
The global Cephalosporin market is projected to grow from US$ 1373.1 million in 2023 to US$ 1346.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of -0.3% during the forecast period.
Market competition is intense. Qilu Antibiotics, Nectar Lifesciences......
Global Metronidazole Market Insights, Forecast to 2029
Published: 21-Sep-2023 Price: US 4900 Onwards Pages: 110
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
The global Metronidazole market is projected to grow from US$ 112.4 million in 2023 to US$ 109.1 million by 2029, at a Compound Annual Growt......
Global Clotrimazole Market Insights, Forecast to 2029
Published: 20-Sep-2023 Price: US 4900 Onwards Pages: 107
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad......
Global Metronidazole Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 19-Sep-2023 Price: US 3380 Onwards Pages: 102
Market Overview of Global Metronidazole market:
According to our latest research, the global Metronidazole market looks promising in the next 5 years. As of 2022, the global Metronidazole market was estimated at USD 145.04 million, and it's anticipated to reach USD 179.89 million in 2028, with a CAGR of 3.65% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Metronidazole market, ......
2023-2031 Report on Global Polymixin Market by Player, Region, Type, Application and Sales Channel
Published: 18-Sep-2023 Price: US 2500 Onwards Pages: 102
This report studies the Polymixin market, covering market size for segment by type (Oral, Injection, etc.), by application (Pigs, Chickens, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Sonneborn, Moresco Corporation, Eastern Petroleum, Wilterng Chemicals, Unicorn Petroleum Industries, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for......
2023-2031 Report on Global Clotrimazole Market by Player, Region, Type, Application and Sales Channel
Published: 18-Sep-2023 Price: US 2500 Onwards Pages: 99
This report studies the Clotrimazole market, covering market size for segment by type (Suppository, Tablet, etc.), by application (Vaginitis, Otomycosis, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bayer, Erregierre, F.I.S., Amoli Organics, Cordenpharma, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Clotrimazole from 2017-2022, ......
Global Cefprozil Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Sep-2023 Price: US 3380 Onwards Pages: 102
Market Overview of Global Cefprozil market:
According to our latest research, the global Cefprozil market looks promising in the next 5 years. As of 2022, the global Cefprozil market was estimated at USD 157.92 million, and it's anticipated to reach USD 184.0 million in 2028, with a CAGR of 2.58% during the forecast years.
Cefprozil is a second-generation cephalosporin antibiotic that can be used to treat bronchitis or other bacterial infections. The cefprozil may be in the f......
Global Cephalexin Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 110
Cephalexin (CAS 15686-71-2), C16H17N3O4S, the formula weight is 347.39, and its form is white and light yellow crystal powder.
The global Cephalexin market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Cephalexin is mainly infected with Gram-positive and negative bacteria, influenza, such as hemorrhagic sepsis, streptococcosis, and is used to treat various inflammatory diseases ......
Global Ribavirin Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 108
Ribavirin (CAS 36791-04-5), C8H12N4O5, the formula weight is 244.2, and its form is white solid.
The global Ribavirin market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Ribavirin is used to prevent parainfluenza, hepatitis A, hepatitis B, hepatitis C, measles, mumps, chickenpox, herpes simplex, herpes zoster, viral keratitis, herpetic stomatitis, and pediatric adenovirus pneum......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
